Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO/CIE 28077:2016, jointly developed by ISO and the International Commission on Illumination (CIE), defines the photocarcinogenesis action spectrum for non-melanoma skin cancers. This standard specifies the relative spectral effectiveness of ultraviolet (UV) radiation in inducing squamous cell carcinoma (SCC) in human skin. The action spectrum is a fundamental tool in photobiology and photomedicine, used to quantify the carcinogenic risk of UV exposure from natural sunlight and artificial UV sources. The standard was developed by CIE Technical Committee 6-54 based on extensive epidemiological and experimental data, including the widely accepted mouse skin tumor model with appropriate corrections for human skin sensitivity.
The action spectrum defined by this standard is wavelength-dependent, covering the UV spectrum from 250 nm to 400 nm. The standard recognizes that not all UV wavelengths are equally carcinogenic — shorter wavelengths (UV-B, 280-315 nm) are significantly more effective at inducing skin cancer than longer wavelengths (UV-A, 315-400 nm). The spectrum provides quantitative weighting factors that enable accurate risk assessment of UV sources for regulatory compliance, occupational health monitoring, and consumer protection applications.
The photocarcinogenesis action spectrum S(λ) is defined mathematically as a piecewise function across the UV wavelength range. From 250 nm to 298 nm, the effectiveness increases with a specific slope; the peak effectiveness occurs at approximately 298 nm (in the UV-B region). From 298 nm to 400 nm, the effectiveness decreases exponentially by approximately four orders of magnitude. The standard provides tabulated values at 1 nm intervals from 250 nm to 400 nm, with linear interpolation permitted between tabulated points. The weighting function is normalized to 1.0 at the reference wavelength (typically 298 nm), with relative effectiveness values ranging from approximately 1.0 at the peak to less than 0.0001 at 400 nm.
| Wavelength (nm) | Relative Effectiveness | Band | Biological Significance |
|---|---|---|---|
| 250 | 0.43 | UV-C | Strong absorption by DNA, but largely filtered by ozone |
| 298 | 1.00 (peak) | UV-B | Peak photocarcinogenic effectiveness |
| 310 | 0.12 | UV-B | Significant contribution in solar UV at earth surface |
| 340 | 0.0012 | UV-A | Reduced but still measurable carcinogenic risk |
| 370 | 0.00019 | UV-A | Low effectiveness, high solar intensity compensates |
| 400 | 0.00008 | UV-A | Upper boundary of UV spectrum for this standard |
The action spectrum is applied by integrating the spectral irradiance of a UV source weighted by the photocarcinogenesis effectiveness function across the 250-400 nm range. This yields the effective irradiance (E_eff) in W/m², which represents the carcinogenic potency of the source. The effective irradiance is calculated as: E_eff = Σ E(λ) × S(λ) × Δλ, where E(λ) is the spectral irradiance of the source and S(λ) is the action spectrum value at each wavelength. This weighted integration is the basis for occupational exposure limits, sunscreen testing protocols, and UV index calculations used in public health warnings.
The ISO/CIE 28077 spectrum is distinct from other UV action spectra used in photobiology. Unlike the CIE erythema (sunburn) action spectrum (ISO 17166), which measures acute skin reddening, the photocarcinogenesis spectrum measures long-term carcinogenic risk. The erythema spectrum peaks at shorter wavelengths and has a different shape in the UV-A region. The standard also differs from the International Commission on Non-Ionizing Radiation Protection (ICNIRP) UV hazard spectrum, which includes protection factors for the eye. These distinctions are important: a UV source that has a low erythemal risk may still pose significant carcinogenic risk due to differences in the spectral weighting functions.
ISO/CIE 28077 plays a critical role in sunscreen efficacy testing. The SPF (Sun Protection Factor) rating is determined by measuring the protection afforded by a sunscreen against UV radiation weighted by the photocarcinogenesis action spectrum. The standard’s spectral weighting function ensures that SPF ratings reflect protection against the most carcinogenic wavelengths, not merely against erythema. This is particularly important for “broad spectrum” claims, which require that a sunscreen provides balanced protection across both UV-B and UV-A wavelengths as weighted by the action spectrum.
The standard is used by regulatory bodies worldwide to classify artificial UV sources including tanning equipment, phototherapy lamps, and industrial UV curing systems. In the European Union, the standard is referenced in EN 60335-2-27 for tanning appliance safety. In the United States, the FDA uses the action spectrum framework for evaluating UV radiation emitting products. Engineers designing UV-emitting products must calculate the weighted effective irradiance of their devices and ensure compliance with applicable exposure limits, typically specified as effective radiant exposure (J/m²) over an 8-hour occupational exposure period.
The global UV Index (UVI), used in daily weather forecasts and public health communications worldwide, is calculated using a weighting function derived from the ISO/CIE 28077 photocarcinogenesis action spectrum combined with the CIE erythema action spectrum. The UV Index converts the weighted solar UV irradiance at the earth’s surface into a simple numerical scale (typically 0 to 11+). Engineers developing UV monitoring instruments, wearable UV sensors, and smartphone-based UV estimation applications must implement the spectral weighting functions defined in this standard to provide accurate UV exposure guidance.